VivoSeq
Other

Preconditioning

0

Pipeline Programs

0

Active Trials

1

Companies Involved

Preconditioning is an early-stage landscape with 0 programs across 1 company. The most active players are Renibus Therapeutics, Inc..

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

13/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

15

clinical trials

Completed10 · 67%
Unknown status3 · 20%
Withdrawn2 · 13%

Trial Activity

15 trials

Desflurane Preconditioning in Hepatectomies
Completed··N/A·NCT03848780·46 enrolled
MicroRNA Mediates Volatile Anesthetics Preconditioning Induced Artery Protection
Unknown status··Phase 4·NCT02678650·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)